Medline (MDLN) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 Jun, 2026Opening remarks and agenda
Welcomed stockholders to the inaugural annual meeting following the IPO, marking the company's 60th anniversary.
Introduced board members, executive team, and independent auditor representatives.
Outlined meeting format, agenda, and voting procedures, ensuring virtual participation parity with in-person meetings.
Financial performance review
Achieved $2.4 billion in new customer signings in 2025, exceeding annual goals.
Continued investments in distribution network automation and technology partnerships.
Expanded product portfolio and piloted an AI-based collaboration with Microsoft.
Board and executive committee updates
All 12 board members were up for re-election at the meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Medline
- Strong Q1 growth, proactive quality management, and raised guidance highlight robust outlook.MDLN
Goldman Sachs 47th Annual Global Healthcare Conference 20269 Jun 2026 - Strong growth and resilience driven by scale, innovation, and customer-focused execution.MDLN
46th Annual William Blair Growth Stock Conference3 Jun 2026 - Secondary sale of 60 million shares highlights strong growth, high margins, and no proceeds to the company.MDLN
Registration filing20 May 2026 - Q1 2026 sales up 10.7%–11% to $7.4B; margins fell, but full-year sales guidance was raised.MDLN
Q1 202612 May 2026 - Key votes include director elections, executive pay, auditor ratification, and sustainability options.MDLN
Proxy filing23 Apr 2026 - 2025 saw double-digit sales growth, a public listing, and enhanced governance and ESG focus.MDLN
Proxy filing23 Apr 2026 - 2025 saw 11.5% sales growth, record signings, and IPO success, with strong 2026 outlook.MDLN
Q4 202516 Apr 2026 - 2026 outlook targets 8%-9% organic growth, margin expansion, and continued market share gains.MDLN
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - 75 million shares offered by selling stockholders; strong recurring revenue and growth outlook.MDLN
Registration Filing3 Mar 2026